CompletedPhase 2

Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus

NCT02175121

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Anaheim Clinical Trials, LLC

Anaheim, California, United States

+18 additional locations

Save this trial

Anaheim Clinical Trials, LLCAnaheim, California, United States
Profil Institute for Clinical Research, Inc.Chula Vista, California, United States
Diablo Clinical Research, Inc.Walnut Creek, California, United States
Avail Clinical Research, LLCDeLand, Florida, United States
SeaView Research, Inc.Miami, Florida, United States
SeaView Research, Inc.Miami, Florida, United States
Compass Research, LLCOrlando, Florida, United States
Miami Research Associates, Inc.South Miami, Florida, United States
MRA Clinical Research, LLCSouth Miami, Florida, United States
MRA Clinical ResearchSouth Miami, Florida, United States
Louisville Metabolic and Atherosclerosis Research CenterLouisville, Kentucky, United States
DaVita Clinical ResearchMinneapolis, Minnesota, United States
Clinilabs, Inc.Eatontown, New Jersey, United States
PRA InternationalMarlton, New Jersey, United States
Buffalo Clinical Research Center, LLCBuffalo, New York, United States
High Point Clinical Trials Center, LLCHigh Point, North Carolina, United States
Community ResearchCincinnati, Ohio, United States
Clinical Trials of Texas, Inc.San Antonio, Texas, United States
Rainier Clinical Research Center, Inc.Renton, Washington, United States